-transparent.png){kind=logo}
The therapeutic effects of alpha-difluoromethylornithine (DFMO) on rats with bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) were examined. Eight-week-old male Wistar rats were given 0.05% BBN in their drinking water for a period of 4 weeks. Therapy (0.1% DFMO in their drinking water) was started at week 4 and all rats were killed at week 60. DFMO was seen to significantly reduce the incidence, the mean number and the total size of tumors. No side-effects of DFMO were noted, except alopecia, which started at month 7 of the therapy.
Related Publications
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
December 1987,
Cancer research,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
October 1989,
Cancer research,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
January 2024,
Methods in molecular biology (Clifton, N.J.),
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
February 1999,
International journal of urology : official journal of the Japanese Urological Association,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
August 1969,
Gan,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
August 1987,
Journal of the National Cancer Institute,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
May 1981,
Cancer research,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
February 1976,
Gan,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
January 1993,
Journal of cancer research and clinical oncology,
M Kawahara, and
T Matsuhashi, and
T Yagishita, and
M Tajima, and
M Matsushima
January 1993,
Anticancer research,
